Clinical Trial Update: Safety of Erythropoietin and Melatonin for Very Preterm Infants With Intraventricular Hemorrhage [Phase 1]

View source ↗

Summary

This Phase 1 trial from Johns Hopkins is evaluating the safety of erythropoietin and melatonin for very preterm infants with intraventricular hemorrhage; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraventricular Hemorrhage of Prematurity

Drugs mentioned

• Epogen (epoetin alfa)
• Melatonin (melatonin)

Snippet

Sponsor: Johns Hopkins University | Conditions: Intraventricular Hemorrhage of Prematurity | Phase 1 | Status: RECRUITING